Cargando…

Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases

BACKGROUND: For more than a decade, direct oral anticoagulants (DOACs) have been approved in clinical practice for multiple indications such as stroke prevention in non-valvular atrial fibrillation treatment of deep vein thrombosis and pulmonary embolism. This study aimed to explore the nature and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alrowily, Abdulrhman, Jalal, Zahraa, Abutaleb, Mohammed H., Osman, Nermin A., Alammari, Maha, Paudyal, Vibhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485560/ https://www.ncbi.nlm.nih.gov/pubmed/34598728 http://dx.doi.org/10.1186/s40545-021-00369-w

Ejemplares similares

Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists’ views and experiences
por: Al Rowily, Abdulrhman, et al.
Publicado: (2023)

Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis
por: Al Rowily, Abdulrhman, et al.
Publicado: (2021)

Direct oral anticoagulant-related medication incidents and pharmacists’ interventions in hospital in-patients: evaluation using reason’s accident causation theory
por: Haque, Hazera, et al.
Publicado: (2021)

Views, experiences and contributory factors related to medication errors associated with direct oral anticoagulants: a qualitative study with physicians and nurses
por: Al Rowily, Abdulrhman, et al.
Publicado: (2022)

Patients’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study
por: Al Rowily, Abdulrhman, et al.
Publicado: (2023)

Perceived barriers and facilitators to uptake of non-traditional roles by pharmacists in Saudi Arabia and implications for COVID-19 pandemic and beyond: a qualitative study using Theoretical Domain Framework
por: Mohammed, Eeman, et al.
Publicado: (2021)

Barriers to monitoring and management of cardiovascular and metabolic health of patients prescribed antipsychotic drugs: a systematic review
por: Ali, Ruba Azfr, et al.
Publicado: (2020)

Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand?
por: Azfr Ali, Ruba Saleh, et al.
Publicado: (2021)

Guideline adherence for cardiometabolic monitoring of patients prescribed antipsychotic medications in primary care: a retrospective observational study
por: Ali, Ruba Azfr, et al.
Publicado: (2023)

Key causes and long-term trends related to emergency department and inpatient hospital admissions of homeless persons in England
por: Paudyal, Vibhu, et al.
Publicado: (2023)

Designing a Clinical Pharmacy Primary Care Intervention for Myocardial Infarction Patients Using a Patient and Public Involvement Discussion
por: Jalal, Zahraa, et al.
Publicado: (2020)

The Role of Pharmacists in Providing Pharmaceutical Care in Primary and Secondary Prevention of Stroke: A Systematic Review and Meta-Analysis
por: Al-Qahtani, Saeed, et al.
Publicado: (2022)

South Asians living in the UK and adherence to coronary heart disease medication: a mixed- method study
por: Jalal, Zahraa, et al.
Publicado: (2018)

Detecting medication errors associated with the use of beta-lactams in the Russian Pharmacovigilance database
por: Kuzmina, Anna V., et al.
Publicado: (2021)

Investigating the incidence, nature, severity and potential causality of medication errors in hospital settings in Qatar
por: Thomas, Binny, et al.
Publicado: (2020)

Complementary and alternative medicines use in COVID-19: A global perspective on practice, policy and research
por: Paudyal, Vibhu, et al.
Publicado: (2022)

Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems
por: Shrestha, Sunil, et al.
Publicado: (2021)

Fatal Events Associated with Adverse Drug Reactions in the Korean National Pharmacovigilance Database
por: Jo, Hyeong-Geun, et al.
Publicado: (2021)

Prevalence, contributing factors, and interventions to reduce medication errors in outpatient and ambulatory settings: a systematic review
por: Naseralallah, Lina, et al.
Publicado: (2023)

Potential and Pitfalls of Pharmacovigilance Databases in Oncology
por: Schlam, Ilana, et al.
Publicado: (2023)

Incidence, nature and causes of medication errors in hospitalised patients in Middle Eastern countries: A systematic review
por: Thomas, Binny, et al.
Publicado: (2017)

Medication errors involving anticoagulants: Data from the Danish patient safety database
por: Henriksen, Jakob Nørgaard, et al.
Publicado: (2017)

Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance Network
por: Lavalle, Carlo, et al.
Publicado: (2022)

Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
por: Allouchery, Marion, et al.
Publicado: (2021)

Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis
por: Shahzad, Haris, et al.
Publicado: (2023)

Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation
por: Ozcan, Gulnihal, et al.
Publicado: (2016)

Signal Detection of Adverse Drug Reactions of Cephalosporins Using Data from a National Pharmacovigilance Database
por: Choi, Jung-Yoon, et al.
Publicado: (2021)

Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
por: Kaplan-Marans, Elie, et al.
Publicado: (2022)

Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow)
por: Barbosa, Luiza Hoehl Loureiro Alves, et al.
Publicado: (2022)

Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance
por: Raschi, Emanuel, et al.
Publicado: (2020)

Pharmacovigilance strategy: opportunities for cross-national learning
por: Fermont, Irene
Publicado: (2019)

Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance”
por: Giugliano, Robert P., et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on the Prescribing Patterns of First-Line Antibiotics in English Primary Care: A Longitudinal Analysis of National Prescribing Dataset
por: Hussain, Alisha Zubair, et al.
Publicado: (2021)

Association of Direct Oral Anticoagulants (DOACs) and Warfarin With Haemorrhagic Risk by Applying Correspondence Analysis to Data From the Italian Pharmacovigilance Database – A Case Study
por: Gaio, Mario, et al.
Publicado: (2021)

Using an Automated Algorithm to Identify Potential Drug-Induced Liver Injury Cases in a Pharmacovigilance Database
por: Pineda Salgado, Liliam, et al.
Publicado: (2021)

Drugs utilization profile in England and Wales in the past 15 years: a secular trend analysis
por: Naser, Abdallah Y., et al.
Publicado: (2022)

Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences
por: Hilda Ampadu, H., et al.
Publicado: (2018)

Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
por: Revet, Alexis, et al.
Publicado: (2020)

Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database
por: Russom, Mulugeta, et al.
Publicado: (2021)

Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database
por: Rudolph, Annette, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7p93v0jb29op5hujova69mndpa